Quantcast

Suffolk Reporter

Thursday, November 7, 2024

FDA issued 38 citations in cities across Suffolk County in Q4 2023

Webp r4rtnb3h764dx5zlstpe2fag0ycm

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

There were eight companies in cities associated with Suffolk County that received FDA citations as a result of eight inspections conducted in the county over the fourth quarter of 2023, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 100% increase over the number of companies cited in the previous quarter.

The citations in the county include:

  • Written MDR procedures have not been maintained.
  • Requirements that must be met by suppliers have not been adequately established.
  • Corrective and preventive action activities and/or results have not been documented.

Most of the companies cited were involved in the Drugs sector. The second most common type of company cited in the time period worked in the .

All of the companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

Companies located within Suffolk County Cities and the citations they received in Q4 2023
Company NameArea of BusinessInspection DateIssue Cited
A. M. Surgical, Inc.Devices10/20/2023DMR - not or inadequately maintained
AMP NutraceuticalsFood and Cosmetics11/21/2023Specifications - identity, purity, strength, composition
AMP NutraceuticalsFood and Cosmetics11/21/2023Specifications met - identity, purity, strength, composition
AMP NutraceuticalsFood and Cosmetics11/21/2023Component - verify identity, dietary ingredient
AMP NutraceuticalsFood and Cosmetics11/21/2023Quality control - reject; specification not met
AMP NutraceuticalsFood and Cosmetics11/21/2023Standard reference materials; criteria for selecting
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023HACCP plan implementation
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Food safety hazards
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Critical limits
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Verification procedures - adequacy
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Signed and dated
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Corrective action per predetermined plan
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Verification - record review - frequency
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Sanitation monitoring
Bob Gosman Company, Inc.Food and Cosmetics10/19/2023Importer verification
Madcar A Division of Century Direct SolutionsDrugs12/20/2023Procedure Deviations Recorded and Justified
Madcar A Division of Century Direct SolutionsDrugs12/20/2023Actual vs. theoretical yields not determined
Madcar A Division of Century Direct SolutionsDrugs12/20/2023Strict control not exercised over labeling issued
Madcar A Division of Century Direct SolutionsDrugs12/20/2023Storage under appropriate conditions
Madcar A Division of Century Direct SolutionsDrugs12/20/2023Labeling Control Records and Label Copies
New York Blood Center EnterprisesBiologics12/22/2023Following manufacturer's instructions
New York Blood Center EnterprisesBiologics12/22/2023Establish, maintain and follow manufacturing SOPs
New York Blood Center EnterprisesBiologics12/22/2023Person performing, test results, interpretation
Phoenix Wipes, Inc.Drugs12/19/2023Procedures not in writing, fully followed
Phoenix Wipes, Inc.Drugs12/19/2023GMP Training Frequency
Phoenix Wipes, Inc.Drugs12/19/2023Equipment Design, Size and Location
Phoenix Wipes, Inc.Drugs12/19/2023Written procedures not established/followed
Phoenix Wipes, Inc.Drugs12/19/2023Component identity verification
Phoenix Wipes, Inc.Drugs12/19/2023Absence of Written Procedures
Phoenix Wipes, Inc.Drugs12/19/2023Expiration date lacking
Phoenix Wipes, Inc.Drugs12/19/2023Record maintenance 1 year (except exempt OTC)
Phoenix Wipes, Inc.Drugs12/19/2023Records reviewed annually
Spirit PharmaceuticalsDrugs11/01/2023Computer control of master formula records
Spirit PharmaceuticalsDrugs11/01/2023Reports of Analysis (Components)
Spirit PharmaceuticalsDrugs11/01/2023Lack of written stability program
W. A. Baum Company, Inc.Devices11/06/2023Lack of Written MDR Procedures
W. A. Baum Company, Inc.Devices11/06/2023Evaluation of suppliers, contractors, etc., requirements
W. A. Baum Company, Inc.Devices11/06/2023Documentation

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS